Article

Multi-omics molecular phenotyping of childhood acute lymphoblastic leukemia cell lines reveals novel drug vulnerabilities

2021-04-29

Abstract excerpt

<title>Abstract</title> Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. Although standard-of-care chemotherapeutics are sufficient for most ALL cases, there are subsets of patients with poor response who relapse in disease. The biology underlying differences between subtypes and their response to therapy has only partially been explained by genetic and transcriptomic profiling. To chara...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7db4a34e-3033-5248-ae17-ae2126d67d12
DOI: 10.21203/rs.3.rs-443839/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multi-omics molecular phenotyping of childhood acute lymphoblastic leukemia cell lines reveals novel drug vulnerabilitiesDOI 10.21203/rs.3.rs-443839/v1Read

Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell linesSemantic proximity Read

Pharmacogenomic Profiling of Pediatric Acute Myeloid Leukemia to Identify Therapeutic Vulnerabilities and Inform Functional Precision MedicineSemantic proximity Read

Application of Omics Analyses in Pediatric B-Cell Acute Lymphoblastic LeukemiaSemantic proximity Read

Multi-omics advances for molecular characterization, precision medicine, and prognostic implications in leukemiaSemantic proximity Read

Novel Biomarkers and Molecular Targets in ALL.Semantic proximity Read

Drug response profiling guides precision therapy in relapsed and refractory childhood acute lymphoblastic leukemiaSemantic proximity Read

Multi-cohort transcriptomic subtyping of B-cell acute lymphoblastic leukemiaSemantic proximity Read

Pharmacogenetics in acute lymphoblastic leukemia.Semantic proximity Read

MEF2D - BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in AdolescentsSemantic proximity Read

Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid Tumors.Semantic proximity Read

Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic LeukemiaSemantic proximity Read

Ex Vivo Drug Responses and Molecular Profiles of 597 Pediatric Acute Lymphoblastic Leukemia PatientsSemantic proximity Read